Global Acne Drugs Market 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	153 Pages	TechNavio	July, 2024	INF19115329

Best Price Guarantee
Price	from $2,500
Length	153 Pages
Publisher	TechNavio
Published Date	July, 2024
SKU	INF19115329

Global Acne Drugs Market 2024-2028

Global Acne Drugs Market 2024-2028

The acne drugs market is forecasted to grow by USD 863 mn during 2023-2028, accelerating at a CAGR of 3.2% during the forecast period. The report on the acne drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by emergence of improved diagnostic modalities, launch of new acne drugs, and increasing cases of acne.

Technavio's acne drugs market is segmented as below:

By Type
Prescription drugs
OTC drugs
By Route Of Administration
Topical
Oral
By Geographical Landscape
North America
Europe
Asia
Rest of World (ROW)

This study identifies the increasing research on gene therapy for dermatologic conditions as one of the prime reasons driving the acne drugs market growth during the next few years. Also, inorganic growth strategies by vendors and innovation in acne treatment will lead to sizable demand in the market.

The report on the acne drugs market covers the following areas:

Acne drugs market sizing
Acne drugs market forecast
Acne drugs market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading acne drugs market vendors that include AndroScience Corp., Astellas Pharma Inc., Bausch Health Companies Inc., Bayer AG, Cipher Pharmaceuticals Inc., Cosmo Pharmaceuticals NV, Elorac Inc., Equalan Pharma Europe Sp. z o.o., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Johnson and Johnson Services Inc., JOURNEY MEDICAL CORP, McKesson Corp., Paratek Pharmaceuticals Inc., Photocure ASA, Reckitt Benckiser Group Plc, Skinvisible Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., Timber Pharmaceuticals LLC, Viatris Inc., and XBiotech Inc.. Also, the acne drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market By Geographical Landscape; Executive Summary - Chart on Market Segmentation by Type; Executive Summary - Chart on Market Segmentation by Route of Administration; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 2.2 Market characteristics; Market characteristics analysis; 2.3 Value chain analysis; Value Chain Analysis
3 Market Sizing: 3.1 Market definition; Offerings of companies included in the market definition; 3.2 Market segment analysis; Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Chart on Global - Market size and forecast 2023-2028 ($ million); Data Table on Global - Market size and forecast 2023-2028 ($ million); Chart on Global Market: Year-over-year growth 2023-2028 (%); Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Global Acne Drugs Market 2018 - 2022; Historic Market Size - Data Table on Global Acne Drugs Market 2018 - 2022 ($ million); 4.2 Type segment analysis 2018 - 2022; Historic Market Size - Type Segment 2018 - 2022 ($ million); 4.3 Route of Administration segment analysis 2018 - 2022; Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million); 4.4 Geography segment analysis 2018 - 2022; Historic Market Size - Geography Segment 2018 - 2022 ($ million); 4.5 Country segment analysis 2018 - 2022; Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis: 5.1 Five forces summary; Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Type: 6.1 Market segments; Chart on Type - Market share 2023-2028 (%); Data Table on Type - Market share 2023-2028 (%); 6.2 Comparison by Type; Chart on Comparison by Type; Data Table on Comparison by Type; 6.3 Prescription drugs - Market size and forecast 2023-2028; Chart on Prescription drugs - Market size and forecast 2023-2028 ($ million); Data Table on Prescription drugs - Market size and forecast 2023-2028 ($ million); Chart on Prescription drugs - Year-over-year growth 2023-2028 (%); Data Table on Prescription drugs - Year-over-year growth 2023-2028 (%); 6.4 OTC drugs - Market size and forecast 2023-2028; Chart on OTC drugs - Market size and forecast 2023-2028 ($ million); Data Table on OTC drugs - Market size and forecast 2023-2028 ($ million); Chart on OTC drugs - Year-over-year growth 2023-2028 (%); Data Table on OTC drugs - Year-over-year growth 2023-2028 (%); 6.5 Market opportunity by Type; Market opportunity by Type ($ million); Data Table on Market opportunity by Type ($ million)
7 Market Segmentation by Route of Administration: 7.1 Market segments; Chart on Route of Administration - Market share 2023-2028 (%); Data Table on Route of Administration - Market share 2023-2028 (%); 7.2 Comparison by Route of Administration; Chart on Comparison by Route of Administration; Data Table on Comparison by Route of Administration; 7.3 Topical - Market size and forecast 2023-2028; Chart on Topical - Market size and forecast 2023-2028 ($ million); Data Table on Topical - Market size and forecast 2023-2028 ($ million); Chart on Topical - Year-over-year growth 2023-2028 (%); Data Table on Topical - Year-over-year growth 2023-2028 (%); 7.4 Oral - Market size and forecast 2023-2028; Chart on Oral - Market size and forecast 2023-2028 ($ million); Data Table on Oral - Market size and forecast 2023-2028 ($ million); Chart on Oral - Year-over-year growth 2023-2028 (%); Data Table on Oral - Year-over-year growth 2023-2028 (%); 7.5 Market opportunity by Route of Administration; Market opportunity by Route of Administration ($ million); Data Table on Market opportunity by Route of Administration ($ million)
8 Customer Landscape: 8.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Chart on Market share By Geographical Landscape 2023-2028 (%); Data Table on Market share By Geographical Landscape 2023-2028 (%); 9.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 9.3 North America - Market size and forecast 2023-2028; Chart on North America - Market size and forecast 2023-2028 ($ million); Data Table on North America - Market size and forecast 2023-2028 ($ million); Chart on North America - Year-over-year growth 2023-2028 (%); Data Table on North America - Year-over-year growth 2023-2028 (%); 9.4 Europe - Market size and forecast 2023-2028; Chart on Europe - Market size and forecast 2023-2028 ($ million); Data Table on Europe - Market size and forecast 2023-2028 ($ million); Chart on Europe - Year-over-year growth 2023-2028 (%); Data Table on Europe - Year-over-year growth 2023-2028 (%); 9.5 Asia - Market size and forecast 2023-2028; Chart on Asia - Market size and forecast 2023-2028 ($ million); Data Table on Asia - Market size and forecast 2023-2028 ($ million); Chart on Asia - Year-over-year growth 2023-2028 (%); Data Table on Asia - Year-over-year growth 2023-2028 (%); 9.6 Rest of World (ROW) - Market size and forecast 2023-2028; Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); 9.7 US - Market size and forecast 2023-2028; Chart on US - Market size and forecast 2023-2028 ($ million); Data Table on US - Market size and forecast 2023-2028 ($ million); Chart on US - Year-over-year growth 2023-2028 (%); Data Table on US - Year-over-year growth 2023-2028 (%); 9.8 Germany - Market size and forecast 2023-2028; Chart on Germany - Market size and forecast 2023-2028 ($ million); Data Table on Germany - Market size and forecast 2023-2028 ($ million); Chart on Germany - Year-over-year growth 2023-2028 (%); Data Table on Germany - Year-over-year growth 2023-2028 (%); 9.9 UK - Market size and forecast 2023-2028; Chart on UK - Market size and forecast 2023-2028 ($ million); Data Table on UK - Market size and forecast 2023-2028 ($ million); Chart on UK - Year-over-year growth 2023-2028 (%); Data Table on UK - Year-over-year growth 2023-2028 (%); 9.10 China - Market size and forecast 2023-2028; Chart on China - Market size and forecast 2023-2028 ($ million); Data Table on China - Market size and forecast 2023-2028 ($ million); Chart on China - Year-over-year growth 2023-2028 (%); Data Table on China - Year-over-year growth 2023-2028 (%); 9.11 Japan - Market size and forecast 2023-2028; Chart on Japan - Market size and forecast 2023-2028 ($ million); Data Table on Japan - Market size and forecast 2023-2028 ($ million); Chart on Japan - Year-over-year growth 2023-2028 (%); Data Table on Japan - Year-over-year growth 2023-2028 (%); 9.12 Market opportunity By Geographical Landscape; Market opportunity By Geographical Landscape ($ million); Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Opportunity/Restraints: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Impact of drivers and challenges in 2023 and 2028; 10.4 Market opportunities/restraints
11 Competitive Landscape: 11.1 Overview; 11.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 11.3 Landscape disruption; Overview on factors of disruption; 11.4 Industry risks; Impact of key risks on business
12 Competitive Analysis: 12.1 Companies profiled; Companies covered; 12.2 Market positioning of companies; Matrix on companies position and classification; 12.3 AndroScience Corp.; AndroScience Corp. - Overview; AndroScience Corp. - Product / Service; AndroScience Corp. - Key offerings; 12.4 Astellas Pharma Inc.; Astellas Pharma Inc. - Overview; Astellas Pharma Inc. - Product / Service; Astellas Pharma Inc. - Key news; Astellas Pharma Inc. - Key offerings; 12.5 Bayer AG; Bayer AG - Overview; Bayer AG - Business segments; Bayer AG - Key news; Bayer AG - Key offerings; Bayer AG - Segment focus; 12.6 Cipher Pharmaceuticals Inc.; Cipher Pharmaceuticals Inc. - Overview; Cipher Pharmaceuticals Inc. - Business segments; Cipher Pharmaceuticals Inc. - Key offerings; Cipher Pharmaceuticals Inc. - Segment focus; 12.7 Cosmo Pharmaceuticals NV; Cosmo Pharmaceuticals NV - Overview; Cosmo Pharmaceuticals NV - Product / Service; Cosmo Pharmaceuticals NV - Key offerings; 12.8 Elorac Inc.; Elorac Inc. - Overview; Elorac Inc. - Product / Service; Elorac Inc. - Key offerings; 12.9 Equalan Pharma Europe Sp. z o.o.; Equalan Pharma Europe Sp. z o.o. - Overview; Equalan Pharma Europe Sp. z o.o. - Product / Service; Equalan Pharma Europe Sp. z o.o. - Key offerings; 12.10 F. Hoffmann La Roche Ltd.; F. Hoffmann La Roche Ltd. - Overview; F. Hoffmann La Roche Ltd. - Business segments; F. Hoffmann La Roche Ltd. - Key news; F. Hoffmann La Roche Ltd. - Key offerings; F. Hoffmann La Roche Ltd. - Segment focus; 12.11 GlaxoSmithKline Plc; GlaxoSmithKline Plc - Overview; GlaxoSmithKline Plc - Business segments; GlaxoSmithKline Plc - Key news; GlaxoSmithKline Plc - Key offerings; GlaxoSmithKline Plc - Segment focus; 12.12 Johnson and Johnson Services Inc.; Johnson and Johnson Services Inc. - Overview; Johnson and Johnson Services Inc. - Business segments; Johnson and Johnson Services Inc. - Key news; Johnson and Johnson Services Inc. - Key offerings; Johnson and Johnson Services Inc. - Segment focus; 12.13 JOURNEY MEDICAL CORP; JOURNEY MEDICAL CORP - Overview; JOURNEY MEDICAL CORP - Product / Service; JOURNEY MEDICAL CORP - Key offerings; 12.14 Paratek Pharmaceuticals Inc.; Paratek Pharmaceuticals Inc. - Overview; Paratek Pharmaceuticals Inc. - Product / Service; Paratek Pharmaceuticals Inc. - Key offerings; 12.15 Photocure ASA; Photocure ASA - Overview; Photocure ASA - Product / Service; Photocure ASA - Key offerings; 12.16 Timber Pharmaceuticals LLC; Timber Pharmaceuticals LLC - Overview; Timber Pharmaceuticals LLC - Product / Service; Timber Pharmaceuticals LLC - Key offerings; 12.17 Viatris Inc.; Viatris Inc. - Overview; Viatris Inc. - Business segments; Viatris Inc. - Key news; Viatris Inc. - Key offerings; Viatris Inc. - Segment focus
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 13.3 Currency conversion rates for US$; Currency conversion rates for US$; 13.4 Research methodology; Research methodology; 13.5 Data procurement; Information sources; 13.6 Data validation; Data validation; 13.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 13.8 Data synthesis; Data synthesis; 13.9 360 degree market analysis; 360 degree market analysis; 13.10 List of abbreviations; List of abbreviations; Exhibits:; Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Type; Exhibits6: Executive Summary - Chart on Market Segmentation by Route of Administration; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Company Market Positioning; Exhibits10: Parent Market; Exhibits11: Data Table on - Parent Market; Exhibits12: Market characteristics analysis; Exhibits13: Value Chain Analysis; Exhibits14: Offerings of companies included in the market definition; Exhibits15: Market segments; Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million); Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million); Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%); Exhibits20: Historic Market Size - Data Table on Global Acne Drugs Market 2018 - 2022 ($ million); Exhibits21: Historic Market Size - Type Segment 2018 - 2022 ($ million); Exhibits22: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million); Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million); Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million); Exhibits25: Five forces analysis - Comparison between 2023 and 2028; Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits31: Chart on Market condition - Five forces 2023 and 2028; Exhibits32: Chart on Type - Market share 2023-2028 (%); Exhibits33: Data Table on Type - Market share 2023-2028 (%); Exhibits34: Chart on Comparison by Type; Exhibits35: Data Table on Comparison by Type; Exhibits36: Chart on Prescription drugs - Market size and forecast 2023-2028 ($ million); Exhibits37: Data Table on Prescription drugs - Market size and forecast 2023-2028 ($ million); Exhibits38: Chart on Prescription drugs - Year-over-year growth 2023-2028 (%); Exhibits39: Data Table on Prescription drugs - Year-over-year growth 2023-2028 (%); Exhibits40: Chart on OTC drugs - Market size and forecast 2023-2028 ($ million); Exhibits41: Data Table on OTC drugs - Market size and forecast 2023-2028 ($ million); Exhibits42: Chart on OTC drugs - Year-over-year growth 2023-2028 (%); Exhibits43: Data Table on OTC drugs - Year-over-year growth 2023-2028 (%); Exhibits44: Market opportunity by Type ($ million); Exhibits45: Data Table on Market opportunity by Type ($ million); Exhibits46: Chart on Route of Administration - Market share 2023-2028 (%); Exhibits47: Data Table on Route of Administration - Market share 2023-2028 (%); Exhibits48: Chart on Comparison by Route of Administration; Exhibits49: Data Table on Comparison by Route of Administration; Exhibits50: Chart on Topical - Market size and forecast 2023-2028 ($ million); Exhibits51: Data Table on Topical - Market size and forecast 2023-2028 ($ million); Exhibits52: Chart on Topical - Year-over-year growth 2023-2028 (%); Exhibits53: Data Table on Topical - Year-over-year growth 2023-2028 (%); Exhibits54: Chart on Oral - Market size and forecast 2023-2028 ($ million); Exhibits55: Data Table on Oral - Market size and forecast 2023-2028 ($ million); Exhibits56: Chart on Oral - Year-over-year growth 2023-2028 (%); Exhibits57: Data Table on Oral - Year-over-year growth 2023-2028 (%); Exhibits58: Market opportunity by Route of Administration ($ million); Exhibits59: Data Table on Market opportunity by Route of Administration ($ million); Exhibits60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits61: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibits62: Data Table on Market share By Geographical Landscape 2023-2028 (%); Exhibits63: Chart on Geographic comparison; Exhibits64: Data Table on Geographic comparison; Exhibits65: Chart on North America - Market size and forecast 2023-2028 ($ million); Exhibits66: Data Table on North America - Market size and forecast 2023-2028 ($ million); Exhibits67: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibits68: Data Table on North America - Year-over-year growth 2023-2028 (%); Exhibits69: Chart on Europe - Market size and forecast 2023-2028 ($ million); Exhibits70: Data Table on Europe - Market size and forecast 2023-2028 ($ million); Exhibits71: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibits72: Data Table on Europe - Year-over-year growth 2023-2028 (%); Exhibits73: Chart on Asia - Market size and forecast 2023-2028 ($ million); Exhibits74: Data Table on Asia - Market size and forecast 2023-2028 ($ million); Exhibits75: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibits76: Data Table on Asia - Year-over-year growth 2023-2028 (%); Exhibits77: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits78: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits79: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits80: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits81: Chart on US - Market size and forecast 2023-2028 ($ million); Exhibits82: Data Table on US - Market size and forecast 2023-2028 ($ million); Exhibits83: Chart on US - Year-over-year growth 2023-2028 (%); Exhibits84: Data Table on US - Year-over-year growth 2023-2028 (%); Exhibits85: Chart on Germany - Market size and forecast 2023-2028 ($ million); Exhibits86: Data Table on Germany - Market size and forecast 2023-2028 ($ million); Exhibits87: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibits88: Data Table on Germany - Year-over-year growth 2023-2028 (%); Exhibits89: Chart on UK - Market size and forecast 2023-2028 ($ million); Exhibits90: Data Table on UK - Market size and forecast 2023-2028 ($ million); Exhibits91: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibits92: Data Table on UK - Year-over-year growth 2023-2028 (%); Exhibits93: Chart on China - Market size and forecast 2023-2028 ($ million); Exhibits94: Data Table on China - Market size and forecast 2023-2028 ($ million); Exhibits95: Chart on China - Year-over-year growth 2023-2028 (%); Exhibits96: Data Table on China - Year-over-year growth 2023-2028 (%); Exhibits97: Chart on Japan - Market size and forecast 2023-2028 ($ million); Exhibits98: Data Table on Japan - Market size and forecast 2023-2028 ($ million); Exhibits99: Chart on Japan - Year-over-year growth 2023-2028 (%); Exhibits100: Data Table on Japan - Year-over-year growth 2023-2028 (%); Exhibits101: Market opportunity By Geographical Landscape ($ million); Exhibits102: Data Tables on Market opportunity By Geographical Landscape ($ million); Exhibits103: Impact of drivers and challenges in 2023 and 2028; Exhibits104: Overview on criticality of inputs and factors of differentiation; Exhibits105: Overview on factors of disruption; Exhibits106: Impact of key risks on business; Exhibits107: Companies covered; Exhibits108: Matrix on companies position and classification; Exhibits109: AndroScience Corp. - Overview; Exhibits110: AndroScience Corp. - Product / Service; Exhibits111: AndroScience Corp. - Key offerings; Exhibits112: Astellas Pharma Inc. - Overview; Exhibits113: Astellas Pharma Inc. - Product / Service; Exhibits114: Astellas Pharma Inc. - Key news; Exhibits115: Astellas Pharma Inc. - Key offerings; Exhibits116: Bayer AG - Overview; Exhibits117: Bayer AG - Business segments; Exhibits118: Bayer AG - Key news; Exhibits119: Bayer AG - Key offerings; Exhibits120: Bayer AG - Segment focus; Exhibits121: Cipher Pharmaceuticals Inc. - Overview; Exhibits122: Cipher Pharmaceuticals Inc. - Business segments; Exhibits123: Cipher Pharmaceuticals Inc. - Key offerings; Exhibits124: Cipher Pharmaceuticals Inc. - Segment focus; Exhibits125: Cosmo Pharmaceuticals NV - Overview; Exhibits126: Cosmo Pharmaceuticals NV - Product / Service; Exhibits127: Cosmo Pharmaceuticals NV - Key offerings; Exhibits128: Elorac Inc. - Overview; Exhibits129: Elorac Inc. - Product / Service; Exhibits130: Elorac Inc. - Key offerings; Exhibits131: Equalan Pharma Europe Sp. z o.o. - Overview; Exhibits132: Equalan Pharma Europe Sp. z o.o. - Product / Service; Exhibits133: Equalan Pharma Europe Sp. z o.o. - Key offerings; Exhibits134: F. Hoffmann La Roche Ltd. - Overview; Exhibits135: F. Hoffmann La Roche Ltd. - Business segments; Exhibits136: F. Hoffmann La Roche Ltd. - Key news; Exhibits137: F. Hoffmann La Roche Ltd. - Key offerings; Exhibits138: F. Hoffmann La Roche Ltd. - Segment focus; Exhibits139: GlaxoSmithKline Plc - Overview; Exhibits140: GlaxoSmithKline Plc - Business segments; Exhibits141: GlaxoSmithKline Plc - Key news; Exhibits142: GlaxoSmithKline Plc - Key offerings; Exhibits143: GlaxoSmithKline Plc - Segment focus; Exhibits144: Johnson and Johnson Services Inc. - Overview; Exhibits145: Johnson and Johnson Services Inc. - Business segments; Exhibits146: Johnson and Johnson Services Inc. - Key news; Exhibits147: Johnson and Johnson Services Inc. - Key offerings; Exhibits148: Johnson and Johnson Services Inc. - Segment focus; Exhibits149: JOURNEY MEDICAL CORP - Overview; Exhibits150: JOURNEY MEDICAL CORP - Product / Service; Exhibits151: JOURNEY MEDICAL CORP - Key offerings; Exhibits152: Paratek Pharmaceuticals Inc. - Overview; Exhibits153: Paratek Pharmaceuticals Inc. - Product / Service; Exhibits154: Paratek Pharmaceuticals Inc. - Key offerings; Exhibits155: Photocure ASA - Overview; Exhibits156: Photocure ASA - Product / Service; Exhibits157: Photocure ASA - Key offerings; Exhibits158: Timber Pharmaceuticals LLC - Overview; Exhibits159: Timber Pharmaceuticals LLC - Product / Service; Exhibits160: Timber Pharmaceuticals LLC - Key offerings; Exhibits161: Viatris Inc. - Overview; Exhibits162: Viatris Inc. - Business segments; Exhibits163: Viatris Inc. - Key news; Exhibits164: Viatris Inc. - Key offerings; Exhibits165: Viatris Inc. - Segment focus; Exhibits166: Inclusions checklist; Exhibits167: Exclusions checklist; Exhibits168: Currency conversion rates for US$; Exhibits169: Research methodology; Exhibits170: Information sources; Exhibits171: Data validation; Exhibits172: Validation techniques employed for market sizing; Exhibits173: Data synthesis; Exhibits174: 360 degree market analysis; Exhibits175: List of abbreviations